EVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Enviva Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, Oct. 25, 2023 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Enviva Inc. (“Enviva” or “the Company”) (NYSE: EVA) and ce
PACW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that PacWest Bancorp Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, Oct. 25, 2023 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against PacWest Bancorp (“PacWest” or “the Company”) (NASDAQ:
LESL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Leslie’s, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, Oct. 25, 2023 /PRNewswire/ — Attorney Advertising– Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Leslie’s, Inc. (“Leslie’s” or “the Company”) (N
Media Advisory – Deputy Prime Minister’s itinerary for Thursday, October 26, 2023
OTTAWA, ON, Oct. 25, 2023 /CNW/ – Note: All times local Calgary, Alberta Private meetings. Toronto, Ontario Private meetings. This document is also available at https://deputypm.canada.ca/en SOURCE Deputy Prime Minister’s Office
Lumen Technologies, Inc. (LUMN) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit
NEW YORK, Oct. 25, 2023 /PRNewswire/ — Attorney Advertising– Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed Lumen Technologies, Inc. (“Lumen” or the “Company”) (NYSE: LUMN) f
DOCN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that DigitalOcean Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, Oct. 25, 2023 /PRNewswire/ — Attorney Advertising– Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against DigitalOcean Holdings, Inc. (“DigitalOcean” or “the Company”
IART INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Integra LifeSciences Holdings Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, Oct. 25, 2023 /PRNewswire/ — Attorney Advertising, Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Integra LifeSciences Holdings Corporation (“Integra” or “the CompanyR
Demand for Sustainable Raw Materials Could Exceed Supply by as Much as 133 Million Tons by 2030
New Report from BCG, Textile Exchange, and Quantis Finds That Fashion and Apparel Brands Can Seize an Average 6% Net Profit Increase by Closing the Raw-Materials Gap LONDON, Oct. 25, 2023 /PRNewswire/ — The fashion and apparel industry is under pressure. More than 85% of leading brands (by sa
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PDD Holdings Inc. – PDD
NEW YORK, Oct. 25, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of PDD Holdings Inc. (“PDD” or the “Company”) (NASDAQ: PDD). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext.
Bridge Biotherapeutics Announces Positive Recommendation from the Independent Data Monitoring Committee of the BBT-877 Phase 2a Study in Idiopathic Pulmonary Fibrosis
The independent data monitoring committee (IDMC) recommended the continuation of the BBT-877 Phase 2a trial based on the initial clinical data from the first 20 participants dosed with the investigational productNo safety concerns were raised based on the evaluation of the data presented at the IDMC
